Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-13

FDA Approved: CLARITIN-D 12 HOUR — Supplemental Application (Bayer HealthCare LLC.)

View source ↗

Summary

FDA approved a supplemental application for Claritin-D 12 Hour, a combination of loratadine and pseudoephedrine sulfate.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Loratadine (Loratadine)
  • Pseudoephedrine sulfate (pseudoephedrine sulfate)

Snippet

SUPPL AP for CLARITIN-D 12 HOUR (LORATADINE AND PSEUDOEPHEDRINE SULFATE)